Trial ID ESR 22-21698 (EIMPRIS) | Maryland Oncology Hematology Trial ID ESR 22-21698 (EIMPRIS) – Maryland Oncology Hematology

Trial ID ESR 22-21698 (EIMPRIS)

Trial Information - Phase II/III

EIMPRIS: Real World Evaluation of the Effectiveness of AZD 7442 for Prevention of SARS-CoV-2 Infection in Immuno-Suppressed Cancer Patients

Protocol ID: ESR 22-21698

Sponsor: American Oncology Partners of MD

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com
or call us at 877-664-7724

Disease Types

Anal, Bladder, Breast, Breast Cancer, Cervical, Colorectal, Endometrial, Esophageal, Gastric, Gastric / GE Junction, Head and Neck, Leukemia, Lung, Lymphoma, MDS, Melanoma, Multiple Myeloma, Ovarian, Ovarian Cancer, Pancreas, Pancreatic Cancer, Prostate, Prostate Cancer, Renal Cancer, Supportive Care, Urothelial, Uterine

Investigator

Narang MD, Mohit

Sponsor

American Oncology Partners of MD

Quality Care Close to Home


View our locations on map!

Sign Up Today For Our E-Newsletter

  • This field is for validation purposes and should be left unchanged.
United in Healing with The US Oncology Network - Maryland Oncology Hematology